NCT01896479
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01896479
Title A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer (EXAMINER)
Acronym EXAMINER
Recruitment Active, not recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Exelixis
Indications
Therapies
Age Groups: senior | adult
Covered Countries SWE | ROU | POL | NLD | ITA | ISR | HUN | HRV | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
St Leonards New South Wales 2065 Australia Details
Herston Queensland 4006 Australia Details
Kurralta Park South Australia 5037 Australia Details
Parkville Victoria 3050 Australia Details
Québec Quebec JIH 5N4 Canada Details
Toronto M5G 2M9 Canada Details
Osijek 31000 Croatia Details
Zagreb 10000 Croatia Details
Zagreb 1000 Croatia Details
Bordeaux Gironde 33076 France Details
Angers Maine-et-Loire 49933 France Details
Lyon Rhône 69373 France Details
Villejuif Val-de-Marne 94805 France Details
Dijon 21079 France Details
Paris 75013 France Details
Strasbourg 67065 France Details
Budapest 1088 Hungary Details
Debrecen 4032 Hungary Details
Jerusalem 91120 Israel Details
Petah Tikva 49100 Israel Details
Safed 13100 Israel Details
Catania CT 95124 Italy Details
Roma RM 00161 Italy Details
Siena SI 53100 Italy Details
Pisa Tuscany 56124 Italy Details
Milan 20133 Italy Details
Padua 35138 Italy Details
Torino 10153 Italy Details
Amsterdam North Holland 1066 CX Netherlands Details
Leiden South Holland 2333 ZA Netherlands Details
Groningen 9713 GZ Netherlands Details
Poznan Greater Poland Voivodeship 60-355 Poland Details
Gliwice Silesian Voivodeship 44-100 Poland Details
Bucharest 10825 Romania Details
Bucharest 11863 Romania Details
Cluj-Napoca 400058 Romania Details
Timișoara 300723 Romania Details
Novosibirsk 630068 Russia Details
Obninsk 249036 Russia Details
Saint Petersburg 197089 Russia Details
Yaroslavl 150040 Russia Details
Goyang Gyeonggido 410769 South Korea Details
Seoul 110744 South Korea Details
Seoul 135-710 South Korea Details
Barcelona 08035 Spain Details
Madrid 28034 Spain Details
Madrid 28046 Spain Details
Lund Skane Ian SE-22185 Sweden Details
Uppsala Uppsala Ian 75185 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field